Strategic Partnerships Konovo is expanding through acquisitions and partnerships, including Rare Patient Voice and Metaforms, and recently collaborated with Litmys. These moves indicate a growing ecosystem approach and potential cross-sell opportunities across audience panels, consulting services, and intelligent survey tools.

Expanded Leadership New hires in India and US leadership (MD India and CCO) alongside a chief compliance and privacy officer signal investment in global growth, enterprise sales, and regulated healthcare research capabilities, creating openings for enterprise deals with regional pharma and CROs.

Healthcare Focus With a global healthcare intelligence focus and access to physicians, KOLs, patients, and caregivers, Konovo offers rich, diverse panels for life sciences studies, enabling sales conversations around faster study recruitment, higher quality insights, and globally scalable data solutions.

Technology Enablement Investments in AI and platforms such as OpenAI, Metaforms programming AI, and integration with Survey Studio suggest opportunities to upsell advanced analytics, automated data collection, and smarter respondent targeting for pharma market research clients.

Financial Scale Revenue in the mid-range eight figures and a sizable employee base position Konovo as a mid-market to upper-mid-market healthcare intelligence vendor, presenting opportunities for multi-year contracts, renewals, and expansion within pharmaceutical brands and agencies seeking scalable research partners.